Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-10-08 00:00:00 ET · period of report 2024-10-07 · accession 0001649094-24-000079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-08 | 2024-10-07 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $109.27 | -5,000 | 28.7K | -15% | -$546.4K |
| D | 2024-10-08 | 2024-10-07 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 33.6K | +17% | +$107.0K |
| D | 2024-10-08 | 2024-10-07 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $0.00 | -5,000 | 169.5K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-07 | S | D | 67 | $111.68 | 28,623 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-07 | M | A | 5,000 | $21.41 | 33,623 | D | — | — | |
| 3 | Common | Common Stock | 2024-10-07 | S | D | 476 | $107.51 | 33,147 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $107.08 to $107.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-10-07 | S | D | 3,147 | $109.55 | 29,004 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $109.18 to $110.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-10-07 | S | D | 996 | $108.69 | 32,151 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $108.085 to $109.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2024-10-07 | S | D | 314 | $110.51 | 28,690 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $110.235 to $111.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Derivative | Stock Option (right to buy) | 2024-10-07 | M | D | 5,000 | $0.00 | 169,497 | D | $21.41 · — to 2032-05-08 | 5,000 Common Stock | (F6) 1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |